Almac Opens Facility for Specialist Storage
New 1277 m³ facility to bring 150 extra controlled drug storage pallets, 450 extra refrigerated cold storage pallets with room for further expansion.
Almac Clinical Service today announced the opening of an additional storage facility at its EU headquarters in Craigavon to meet the increased demands for cold-chain & controlled clinical supply storage.
The huge new facility has been fuelled by unprecedented demand in the marketplace for provision of supply services catering for biotech and pharma companies requiring refrigerated or controlled storage requirements for their clinical supplies.
This new purpose built facility contains a 1277m³ vault, holding an additional 150 pallet spaces for controlled drug storage. The facility provides 450 extra pallet spaces for storage of refrigerated material (2-8°C), with room for an additional future expansion of 400 pallets. This extra capacity is in addition to that already available at the site.
This latest development is in line with Almac's continued expansion plans, as already reflected in the significant expansions for cold storage at the groups Durham (NC) and Audubon (PA) sites. This new state-of-the-art facility combined with Almac’s global depot network ensures Almac continues as a world leader in the provision of clinical supply services and solutions.
Robert Dunlop, President of Almac Clinical Services said: ‘The opening of the new storage warehouse is a testimony to our commitment to providing the highest quality of service and available capacity to our customers. As demand for both controlled drug and cold chain storage has grown steadily in recent times, we must provide our offerings in line with market demands. This positions Almac firmly as a market leader for clinical supplies, offering unrivalled cold chain & controlled drug resources for our client base.’
About Almac Clinical Services
Almac Clinical Services is a global company focused on clinical trial supply solutions, with sites in Craigavon (UK), Audubon (PA, USA) and Durham (NC, USA). Almac Clinical Services enables clients to meet their trial start dates by leveraging skilled and experienced personnel coupled with robust quality systems and operational flexibility. Services provided include blinding, packaging, labelling, global distribution, QP release, analytical testing, drug supply management and online randomization.
About Almac
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, product development, clinical trial supply and technology (IVRS/EDC), to commercial-scale manufacture. Almac provides services to over 600 companies including all the world leaders in the pharmaceutical and biotech sectors.
The company has almost 2,200 employees and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company's new $100m North American Headquarters started in July 08 and is expected to be completed 2010.
To find out more about Almac visit
www.almacgroup.com
.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
